[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337133-105":59,"doc-detail-337133-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","proteomic-analysis-of-biomarkers-predicting-treatment-response-in-patients-with-head-and-neck-cancers","Proteomic Analysis of Biomarkers Predicting Treatment Response in Patients with Head and Neck Cancers","","Head and neck cancers represent a major and rising cause of cancer mortality worldwide, with squamous cell carcinoma as the most prevalent subtype. This study used serum proteomic profiling to identify clinical biomarkers predicting response in patients receiving chemoradiotherapy. Fifteen participants were classified as responders or non-responders, with serum collected before and after radiotherapy. Proteins were quantified using Bradford assay followed by nano-HPLC–MS/MS and Progenesis QI, yielding 55 differentially expressed proteins. Three proteins, ADIPOQ, HEY2, and FUT10, showed high-confidence signals as potential predictive biomarkers.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/proteomic-analysis-of-biomarkers-predicting-treatment-response-in-patients-with-head-and-neck-cancers/337133/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/proteomic-analysis-of-biomarkers-predicting-treatment-response-in-patients-with-head-and-neck-cancers/337133.png","ImageObject",300,407,{"name":92,"@type":93},"Clementine","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What goal does the study address?","Question",{"text":113,"@type":114},"To identify serum proteomic biomarkers that can predict treatment response in head and neck cancer patients undergoing chemoradiotherapy.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were patients classified for analysis?",{"text":118,"@type":114},"Patients were categorized as responders (R) or non-responders (NR) based on their treatment response.",{"name":120,"@type":111,"acceptedAnswer":121},"Which proteins were highlighted as potential predictive biomarkers?",{"text":122,"@type":114},"ADIPOQ, HEY2, and FUT10 were identified as potential predictive biomarkers with high-confidence signals from the protein abundance analysis.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},337133,1790189368,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":26,"preview_page_count":19,"preview_urls":146},1374391974564,"https://ap-avatar.wpscdn.com/avatar/14000253aa45c000a9e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779874745381141002","Article  \nProteomic Analysis of Biomarkers Predicting Treatment Response in Patients with Head and Neck Cancers  \nEmeshaw Damtew Zebene 1,2, Rita Lombardi 3, Biagio Pucci 4, *, Hagos Tesfay Medhin 1, Edom Seife 5, Elena Di Gennaro 4, Alfredo Budillon 6 and Gurja Belay Woldemichael 2  \nCitation: Zebene, E.D.; Lombardi, R.; Pucci, B.; Medhin, H.T.; Seife, E.; Di Gennaro, E.; Budillon, A.; Woldemichael, G.B. Proteomic Analysis of Biomarkers Predicting Treatment Response in Patients with Head and Neck Cancers. Int. J. Mol. Sci. 2024, 25, 12513. [https://](https://)[ ](https://)[doi.org/10.3390/ijms252312513](doi.org/10.3390/ijms252312513)  \nAcademic Editor: Maria Gazouli  \nReceived: 25 October 2024  \nRevised: 18 November 2024  \nAccepted: 19 November 2024  \nPublished: 21 November 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Nuclear Medicine Unit, Department of Internal Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa 9086, Ethiopia; [emeshaw.damtew@aau.edu.et](emeshaw.damtew@aau.edu.et) (E.D.Z.); [hagos.tesfay@aau.edu.et](hagos.tesfay@aau.edu.et) (H.T.M.)  \n2 Department of Microbial Cellular and Molecular Biology, College of Natural and Computational Sciences, Addis Ababa University, Addis Ababa 9086, Ethiopia; [gurja.belay@aau.edu.et](gurja.belay@aau.edu.et)  \n3 Experimental Animal Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, 80131 Naples, Italy; [r.lombardi@istitutotumori.na.it](r.lombardi@istitutotumori.na.it)  \n4 Experimental Pharmacology Unit-Laboratory of Naples and Mercogliano (AV), Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, 80131 Naples, Italy; e.digennaro@istitutotumori.na.it  \n5 Radiotherapy Center, College of Health Sciences, Addis Ababa University, Addis Ababa 9086, Ethiopia; [edomseife3@gmail.com](edomseife3@gmail.com)  \n6 Scientific Directorate, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, 80131 Naples, Italy; [a.budillon@istitutotumori.na.it](a.budillon@istitutotumori.na.it)  \n* [Correspondence: b.pucci@istitutotumori.na.it](Correspondence: b.pucci@istitutotumori.na.it); Tel.: +39-3-755-359-673  \nAbstract: Head and neck cancers (HNCs) are the sixth most commonly diagnosed cancer and the eighth leading cause of cancer-related mortality worldwide, with squamous cell carcinoma being the most prevalent type. The global incidence of HNCs is steadily increasing, projected to rise by approximately 30% per year by 2030, a trend observed in both developed and undeveloped countries. This study involved serum proteomic profiling to identify predictive clinical biomarkers in cancer patients undergoing chemoradiotherapy (CRT) . Fifteen HNC patients at Tikur Anbessa Specialized Hospital, Radiotherapy (RT) center in Addis Ababa were enrolled. Serum samples were collected before and after RT, and patients were classified as responders (R) or non-responders (NR) . Protein concentrations in the serum were determined using the Bradford assay, followed by nano-HPLC– MS/MS for protein profiling. Progenesis QI for proteomics identified 55 differentially expressed proteins (DEPs) between R and NR, with a significance of p \u003C 0.05 and a fold-change (FC) ≥ 1.5. The top five-up-regulated proteins included MAD1L1, PSMC2, TRIM29, C5, and SERPING1, while the top five-down-regulated proteins were RYR1, HEY2, HIF1A, TF, and CNN3 . Notably, about 16.4% of the DEPs were involved in cellular responses to DNA damage from cancer treatments, encompassing proteins related to deoxyribonucleic acid (DNA) damage sensing, checkpoint activation, DNA repair, and apoptosis/cell cycle regulation. The analysis of the relative abundance of ten proteins with high confidence scores ident","cbCaikkxbqodU0bg","https://ap.wps.com/l/cbCaikkxbqodU0bg","pdf",4873675,24,"English","# Introduction\n## Overview of head and neck cancers and risk factors\n# Methods\n## Serum proteomic profiling workflow\n## Patient classification and sampling\n# Results\n## Differentially expressed proteins between responders and non-responders\n## Pathways related to DNA damage response\n## Candidate predictive biomarkers","[{\"question\":\"What goal does the study address?\",\"answer\":\"To identify serum proteomic biomarkers that can predict treatment response in head and neck cancer patients undergoing chemoradiotherapy.\"},{\"question\":\"How were patients classified for analysis?\",\"answer\":\"Patients were categorized as responders (R) or non-responders (NR) based on their treatment response.\"},{\"question\":\"Which proteins were highlighted as potential predictive biomarkers?\",\"answer\":\"ADIPOQ, HEY2, and FUT10 were identified as potential predictive biomarkers with high-confidence signals from the protein abundance analysis.\"}]","Proteomic Analysis of Biomarkers Predicting Treatment Response in Patients with Head and Neck Cancers | PDF",1790017822,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aeaaee86bc538876cf0a47a80b24297d.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/74b3c47ac12e57917ca762c32525514a.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b72ba53b8ab105ecffa839c5711d6156.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bd274fbced2929ccc1526f67cc6d16bb.webp",980,1385]